# OnCo record apixaban (drug). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/drugs/apixaban/>
  a schema:Drug ;
  onco:kind "drug" ;
  schema:identifier "apixaban" ;
  schema:name "Apixaban"@en ;
  schema:description "Apixaban is a blood-thinning tablet. Guidelines now accept it for treating a clot in most people with cancer, and for preventing clots in some people starting chemotherapy who are at higher risk."@en ;
  schema:url <https://onco.cc/drugs/apixaban/> ;
  schema:dateModified "2026-11-11"^^xsd:date ;
  schema:sameAs <https://en.wikipedia.org/wiki/Apixaban> ;
  schema:citation <https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=1523ab32-2c2c-6501-e063-6394a90aa0b3>, <https://doi.org/10.1016/S1470-2045(22)00160-7>, <https://doi.org/10.1200/JCO.23.00294> ;
  onco:status "approved" ;
  onco:tag "supportive", "generic", "supportive-care-gaps-2026-11" ;
  onco:modality "Direct oral anticoagulant (factor Xa inhibitor, tablet)" ;
  schema:alternateName "Eliquis" ;
  onco:approval "US 2012: Stroke prevention in non-valvular atrial fibrillation; DVT prophylaxis after hip or knee replacement; treatment of DVT and PE and reduction of recurrence" ;
  onco:related <https://onco.cc/drugs/rivaroxaban/>, <https://onco.cc/drugs/edoxaban/>, <https://onco.cc/drugs/dalteparin/> ;
  onco:technologies <https://onco.cc/technologies/cancer-associated-thrombosis/> ;
  onco:terms <https://onco.cc/terms/vte/> ;
  onco:trials <https://onco.cc/trials/nct07160686/> ;
  onco:keyPapers <https://onco.cc/key-papers/paper-key-j-clin-oncol/> .